Cargando…

Large-scale real-life analysis of survival and usage of therapies in multiple myeloma

Survival in multiple myeloma has improved significantly in recent years, especially in young patients. We reviewed the evolution of the survival of patients with MM in three groups based on age at MM diagnosis over three time periods between 1999 and 2020 at our 12 de Octubre Hospital institution (H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopez-Muñoz, N., Hernández-Ibarburu, G., Alonso, R., Sanchez-Pina, J. M., Ayala, R., Calbacho, M., Cuellar, C., Cedena, M. T., Jiménez-Ubieto, A., Iñiguez, R., Pedrera, M., Cruz, J., Meloni, L., Pérez-Rey, D., Serrano, P., de la Cruz, J., Martinez-Lopez, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357768/ https://www.ncbi.nlm.nih.gov/pubmed/37468911 http://dx.doi.org/10.1186/s13045-023-01474-w

Ejemplares similares

Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
por: Lopez-Muñoz, N., et al.
Publicado: (2023)

P928: REAL-LIFE ANALYSIS OF THE MULTIPLE MYELOMA PATIENT’S SURVIVAL IN A LARGE COHORT OF PATIENTS
por: Lopez-Muñoz, N., et al.
Publicado: (2022)

Impact of COVID-19 in patients with multiple myeloma based on a global data network
por: Martinez-Lopez, J., et al.
Publicado: (2021)

P948: REAL-WORLD EVIDENCE OF BISPHOSPHONATES FOR MULTIPLE MYELOMA
por: Muñoz, Maria Nieves Lopez, et al.
Publicado: (2023)

Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure
por: Zamanillo, Irene, et al.
Publicado: (2023)

Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network
por: Sanz, A., et al.
Publicado: (2022)

P1328: SUCCESFUL TREATMENT OF GRAFT FAILURE IN AUTOLOGOUS STEM CELL TRANSPLANTATION WITH CYCLOSPORINE
por: Cubillas, D., et al.
Publicado: (2022)

Procalcitonin-guided antibiotic usage - addressing heterogeneity in meta-analysis
por: Birajdar, Amit Ravindra, et al.
Publicado: (2018)

Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
por: Chakraborty, Rajshekhar, et al.
Publicado: (2021)

The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements
por: Cedena, Maria-Teresa, et al.
Publicado: (2020)

Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
por: Poza, María, et al.
Publicado: (2021)

Comments on “Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial”
por: Moran, Jose M., et al.
Publicado: (2017)

Oprozomib in patients with newly diagnosed multiple myeloma
por: Hari, Parameswaran, et al.
Publicado: (2019)

hMSCs as an alternative therapeutic option for asthma with neutrophil mediated inflammation
por: Cruz, Fernanda F., et al.
Publicado: (2018)

PB2091: INFLUENCE OF HISTOLOGICAL GRADE IN CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME OF FOLICULAR LYMPHOMA
por: Zamanillo, I., et al.
Publicado: (2022)

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma
por: Martinez-Lopez, J, et al.
Publicado: (2017)

A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma
por: Spencer, Andrew, et al.
Publicado: (2019)

Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)
por: Alegre, Adrián, et al.
Publicado: (2022)

Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
por: Sivaraj, Dharshan, et al.
Publicado: (2018)

Extreme body mass index and survival in newly diagnosed multiple myeloma patients
por: Shah, Urvi A., et al.
Publicado: (2023)

P845: IDENTIFICATION OF MULTIPLE MYELOMA BIOMARKERS VIA LIQUID BIOPSY BASED ON CELL-FREE DNA USING A CAPTURE-HYBRIDIZATION PANEL
por: Buenache Cuenda, N., et al.
Publicado: (2022)

Community treatment orders in England: review of usage from national data
por: Bennett, Daniel M., et al.
Publicado: (2018)

P702: APPLICATION OF NEXT GENERATION SEQUENCING (NGS) FOR MINIMAL RESIDUAL DISEASE (MRD) AND CHIMERISM MONITORING IN MYELODYSPLASTIC SYNDROME (MDS) AFTER ALLOGENIC STEM CELL TRANSPLANTATION (ASCT)
por: Zamanillo, Irene, et al.
Publicado: (2023)

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
por: Shah, Vallari, et al.
Publicado: (2020)

The New British Pharmacopœia and Indian Usage
Publicado: (1934)

Impact of mitochondrial DNA mutations in multiple myeloma
por: Hoang, Phuc H., et al.
Publicado: (2020)

P1132: PET INTERIM RESULTS PREDICT PROGRESSION-FREE-SURVIVAL IN FOLLICULAR LYMPHOMA PATIENTS WITH ADVANCED STAGE
por: Poza, M., et al.
Publicado: (2022)

Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect(®) MM Registry
por: Lee, Hans C., et al.
Publicado: (2021)

Paracetamol usages regulation: A need of the hour
por: Manna, Subhanwita, et al.
Publicado: (2022)

VV-ECMO usage in ARDS due to COVID-19: Clinical, practical and ethical considerations
por: Hoyler, Marguerite M., et al.
Publicado: (2020)

Dissecting racial disparities in multiple myeloma—clues from differential immunoglobulin levels
por: Bunce, C. M., et al.
Publicado: (2020)

Telemedicine for postoperative consultations following vitrectomy for retinal detachment repair during the COVID-19 crisis: a patient satisfaction survey
por: Shahid, S.M., et al.
Publicado: (2021)

Internal mammary artery harvesting with its distal end occluded
por: López-de la Cruz, Yoandy, et al.
Publicado: (2019)

Racial differences as predictors of outcomes in young patients with multiple myeloma
por: Bao, Alicia, et al.
Publicado: (2022)

Noninvasive ventilation usage time and survival rate in patients with acute respiratory failure: some key insights
por: Madney, Yasmin M., et al.
Publicado: (2020)

Infectious complications of bispecific antibody therapy in patients with multiple myeloma
por: Sim, Beatrice Z., et al.
Publicado: (2023)

Detection of myeloma cell-derived microvesicles: a tool to monitor multiple myeloma load
por: Liu, Zhao-Yun, et al.
Publicado: (2023)

The correct usage of the term “low-birth-weight infant”
por: Cizmeci, Mehmet Nevzat, et al.
Publicado: (2013)

Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma
por: Coffey, David G., et al.
Publicado: (2019)

Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry
por: Noori, Somayya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1cphhssnbl0qpvpj6iu6bifris